This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Disease (GERD) Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Disease (GERD) Drugs and Devices. This report contains market size and forecasts of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in global, including the following market information:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Medication Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastroesophageal Reflux Disease (GERD) Drugs and Devices include AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics and Aros Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastroesophageal Reflux Disease (GERD) Drugs and Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, by Type, 2022 (%)
- Medication
- Minimally Invasive Surgery
- Invasive Surgery
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, by Application, 2022 (%)
- Heartburn
- Acid reflux disorders
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca, Plc.
- Addex Therapeutics
- Takeda Pharmaceutical Company Limited
- Rottapharm (Meda AB)
- Pfizer, Inc.
- Eisai Co. Ltd.
- The Procter & Gamble Company
- Mederi Therapeutics
- Aros Pharma
- Torax Medical, Inc.
- BD
- EndoGastric Solutions
- Medigus Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, market overview.
Chapter 2: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size in revenue.
Chapter 3: Detailed analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
